Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,489,218
  • Shares Outstanding, K 126,312
  • Annual Sales, $ 439,440 K
  • Annual Income, $ 76,710 K
  • 60-Month Beta 1.44
  • Price/Sales 3.24
  • Price/Cash Flow 11.42
  • Price/Book 5.01
Trade DVAX with:

Options Overview Details

View History
  • Implied Volatility 88.28% ( +6.07%)
  • Historical Volatility 95.12%
  • IV Percentile 56%
  • IV Rank 43.92%
  • IV High 117.70% on 08/11/21
  • IV Low 65.24% on 06/16/21
  • Put/Call Vol Ratio 0.71
  • Today's Volume 530
  • Volume Avg (30-Day) 1,423
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 44,538
  • Open Int (30-Day) 43,448

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.22
  • Number of Estimates 3
  • High Estimate 0.23
  • Low Estimate 0.21
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +1,000.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.26 +62.40%
on 05/12/22
11.85 -0.55%
on 05/25/22
+1.84 (+18.49%)
since 04/25/22
3-Month
7.26 +62.40%
on 05/12/22
13.02 -9.45%
on 03/01/22
-0.69 (-5.53%)
since 02/25/22
52-Week
7.26 +62.40%
on 05/12/22
21.39 -44.88%
on 11/04/21
+4.16 (+54.52%)
since 05/25/21

Most Recent Stories

More News
Dynavax (DVAX) Up as EMA Accepts Valneva's COVID-19 Vaccine MAA

Dynavax (DVAX) gains as the EMA accepts partner Valneva's MAA for COVID-19 vaccine.

DVAX : 11.79 (+4.52%)
GERN : 1.2900 (+1.57%)
ALKS : 28.85 (+1.76%)
VALN : 23.33 (+1.52%)
Why Dynavax Stock Blasted 16% Higher Today

One of its vaccine partners had some encouraging regulatory news to report.

DVAX : 11.79 (+4.52%)
VALN : 23.33 (+1.52%)
Why Dynavax Stock Won on a Losing Monday for the Market

The company earns an Emergency Use Authorization from a well-off Middle Eastern country.

PFE : 53.71 (+0.56%)
DVAX : 11.79 (+4.52%)
VALN : 23.33 (+1.52%)
Dynavax Technologies (DVAX) Q1 2022 Earnings Call Transcript

DVAX earnings call for the period ending March 31, 2022.

DVAX : 11.79 (+4.52%)
Dynavax Technologies (DVAX) Misses Q1 Earnings and Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -8.33% and 3.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

DVAX : 11.79 (+4.52%)
HOOK : 1.5300 (+4.08%)
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance...

ASEP.CN : 0.300 (unch)
SEPSF : 0.2013 (+0.65%)
IBRX : 3.50 (-4.89%)
DVAX : 11.79 (+4.52%)
ALLO : 7.36 (+0.27%)
ENSC : 0.5249 (+8.52%)
Why Dynavax Stock Was Winning This Week

Several coronavirus vaccines using the company's adjuvant are advancing up the regulatory ladder.

DVAX : 11.79 (+4.52%)
Why BioNTech, Dynavax, Novavax, and Pfizer Stocks Are Jumping Today

The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.

BNTX : 154.67 (+0.11%)
DVAX : 11.79 (+4.52%)
NVAX : 46.13 (-0.88%)
PFE : 53.71 (+0.56%)
ChemoCentryx (CCXI) Q4 Earnings and Sales Miss Estimates

ChemoCentryx (CCXI) posts a wider year-over-year loss in the fourth quarter and sales miss estimates. Lead drug Tavneos has been launched in the United States.

DVAX : 11.79 (+4.52%)
VRTX : 270.84 (+0.88%)
CCXI : 21.71 (+1.40%)
AXSM : 25.27 (-2.99%)
Why Dynavax Stock Dipped on Tuesday

Investors weren't inspired by the bitoech's mixed Q4.

DVAX : 11.79 (+4.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

3rd Resistance Point 12.96
2nd Resistance Point 12.41
1st Resistance Point 12.10
Last Price 11.79
1st Support Level 11.23
2nd Support Level 10.68
3rd Support Level 10.37

See More

52-Week High 21.39
Fibonacci 61.8% 15.99
Fibonacci 50% 14.32
Fibonacci 38.2% 12.66
Last Price 11.79
52-Week Low 7.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar